UCL Spinouts Feature in Industrial Strategy Life Sciences Sector Deal Two

6 December 2018

The government has published the second Life Sciences Sector Deal, which outlines public and private sector investments into the sector.

Investments into three UCL spinouts Orchard Therapeutics, Autolus and Freeline Therapeutics highlight the interest in investment into UK life science expertise.

The three companies have raised significant investment this year.  Orchard Therapeutics and Autolus both filed for IPO on NASDAQ earlier in the year, with Autolus raising £120million and Orchard Therapeutics raising £175million, in addition to series C financing of £117million. Freeline Therapeutics also raised over £88million in its series B funding round earlier in the year.

Read more: here